Roche Diagnostics CEO Is No Ugly Duckling: Schwan Picked To Head Parent Corp.
Executive Summary
Roche Diagnostics CEO Severin Schwan will succeed Franz Humer as CEO of Roche, reflecting a two-fold strategy to separate the chairman and CEO roles and to effect a generational management transition, the drug and diagnostics giant announced July 19
You may also be interested in...
Roche CEO Severin Schwan: Fueled By Innovation, Emerging Markets
Roche’s CEO Severin Schwan says the Swiss group’s recent revamps, lack of patent expiries, and ongoing drug innovations give the world’s largest maker of cancer drugs a strong position to expand its sales globally, helped by new cutting-edge therapies and creative business approaches.
Roche Mantra Is “Pipeline, Pipeline, Pipeline;” R&D Surge Continues In 2008
Roche spending increases on pharmaceutical research and development will continue to outpace sales gains in 2008, company executives said during the firm's fourth quarter financial review Jan. 30
Roche Mantra Is “Pipeline, Pipeline, Pipeline;” R&D Surge Continues In 2008
Roche spending increases on pharmaceutical research and development will continue to outpace sales gains in 2008, company executives said during the firm's fourth quarter financial review Jan. 30